Abstract
Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disorder characterized by the early onset of colorectal cancer (CRC) linked to germline defects in Mismatch Repair (MMR) genes. We present here, the first molecular study of the correlation between CRC and mutations occurring in these genes performed in twenty-one unrelated Algerian families. The presence of germline mutations in MMR genes, MLH1, MSH2 and MSH6 genes was tested by sequencing all exons plus adjacent intronic sequences and Multiplex ligand-dependent probe amplification (MLPA) for testing large genomic rearrangements. Pathogenic mutations were identified in 20 % of families with clinical suspicion on HNPCC. Two novel variants described for the first time in Algerian families were identified in MLH1, c.881_884delTCAGinsCATTCCT and a large deletion in MSH6 gene from a young onset of CRC. Moreover, the variants of MSH2 gene: c.942+3A>T, c.1030C>T, the most described ones, were also detected in Algerian families. Furthermore, the families HNPCC caused by MSH6 germline mutation may show an age of onset that is comparable to this of patients with MLH1 and MSH2 mutations. In this study, we confirmed that MSH2, MLH1, and MSH6 contribute to CRC susceptibility. This work represents the implementation of a diagnostic algorithm for the identification of Lynch syndrome patients in Algerian families.
Similar content being viewed by others
References
Balaguer F, Castells A (2007) Identification of Lynch syndrome: are we close to the best strategy? Gastroenterology 133:353–355. doi:10.1053/j.gastro.2007.05.036
Vasen HFA, Möslein G, Alonso A et al (2010) Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 9:109–115. doi:10.1007/s10689-009-9291-3
Berginc G, Bracko M, Ravnik-Glavac M, Glavac D (2009) Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome. Fam Cancer 8:421–429. doi:10.1007/s10689-009-9258-4
Silva FCCD, Valentin MD, Ferreira FDO et al (2009) Mismatch repair genes in Lynch syndrome: a review. São Paulo Med J Rev Paul Med 127:46–51
Peltomäki P (2014) Epigenetic mechanisms in the pathogenesis of Lynch syndrome. Clin Genet 85:403–412. doi:10.1111/cge.12349
Tutlewska K, Lubinski J, Kurzawski G (2013) Germline deletions in the EPCAM gene as a cause of Lynch syndrome—literature review. Hered Cancer Clin Pract 11:9. doi:10.1186/1897-4287-11-9
Ahmed S, El houari A (2013) 43 000 nouveaux cas de cancer enregistés. Algerie360.com. Information et Actualité sur l’Algérie. www.Algerie360.com/algerie/oncologie-43000-nouveaux-cas-de-Cancer-enregistés/. Accessed 7 May 2013
Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Colon Rectum 34:424–425
Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116:1453–1456
Rodriguez-Bigas MA, Boland CR, Hamilton SR et al (1997) A National Cancer Institute Workshop on hereditary non-polyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758–1762
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Thompson BA, Spurdle AB, Plazzer J-P et al (2014) Application of a 5-tiered scheme for standardized classification of 2360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet 46:107–115. doi:10.1038/ng.2854
Peltomäki P, Vasen H (2004) Mutations associated with HNPCC predisposition—update of ICG-HNPCC/INSiGHT mutation database. Markers 20:269–276
Nakamura K, Banno K, Yanokura M et al (2014) Features of ovarian cancer in Lynch syndrome (review). Mol Clin Oncol 2:909–916. doi:10.3892/mco.2014.397
Liu B, Parsons RE, Hamilton SR et al (1994) hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 54:4590–4594
Warden G, Harnett D, Green J et al (2013) A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity. Clin Genet 84:522–530. doi:10.1111/cge.12080
Pensotti V, Radice P, Presciuttini S et al (1997) Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes. Genes Chromosom Cancer 19:135–142
Valentin MD, da Silva FC, dos Santos EMM et al (2011) Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. Fam Cancer 10:641–647. doi:10.1007/s10689-011-9461-y
Chan TL, Yuen ST, Chung LP et al (1999) Frequent microsatellite instability and mismatch repair gene mutations in young Chinese patients with colorectal cancer. J Natl Cancer Inst 91:1221–1226
Froggatt NJ, Joyce JA, Davies R et al (1995) A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome. Lancet 345:727
Grandval P, Fabre AJ, Gaildrat P et al (2013) UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families. Database J Biol Databases Curation. doi:10.1093/database/bat036
Bartosova Z, Fridrichova I, Bujalkova M et al (2003) Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in Slovakia. Hum Mutat 21:449. doi:10.1002/humu.9127
Rey J-M, Noruzinia M, Brouillet J-P et al (2004) Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer. Cancer Genet Cytogenet 155:149–151. doi:10.1016/j.cancergencyto.2004.03.012
Auclair J, Busine MP, Navarro C et al (2006) Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 27:145–154. doi:10.1002/humu.20280
Chao EC, Velasquez JL, Witherspoon MSL et al (2008) Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat 29:852–860. doi:10.1002/humu.20735
Moussa SA-B, Moussa A, Kourda N et al (2011) Lynch syndrome in Tunisia: first description of clinical features and germline mutations. Int J Colorectal Dis 26:455–467. doi:10.1007/s00384-010-1129-9
Pistorius S, Görgens H, Plaschke J et al (2007) Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett 248:89–95. doi:10.1016/j.canlet.2006.06.002
Martínez-Bouzas C, Ojembarrena E, Beristain E et al (2007) High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country. Cancer Lett 255:295–299. doi:10.1016/j.canlet.2007.05.004
Bunyan DJ, Eccles DM, Sillibourne J et al (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155–1159. doi:10.1038/sj.bjc.6602121
Baudhuin LM, Ferber MJ, Winters JL et al (2005) Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients. Gastroenterology 129:846–854. doi:10.1053/j.gastro.2005.06.026
Klift H, Wijnen J, Wagner A et al (2005) Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosom Cancer 44:123–138. doi:10.1002/gcc.20219
Umar A, Boland CR, Terdiman JP et al (2004) Revised Bethesda guidelines for hereditary non-polyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268
Piñol V, Castells A, Andreu M et al (2005) Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary non-polyposis colorectal cancer. JAMA 293:1986–1994. doi:10.1001/jama.293.16.1986
Pérez-Cabornero L, Infante M, Velasco E et al (2013) Genotype-phenotype correlation in MMR mutation-positive families with Lynch syndrome. Int J Colorectal Dis 28:1195–1201. doi:10.1007/s00384-013-1685-x
Berends MJW, Wu Y, Sijmons RH et al (2002) Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 70:26–37. doi:10.1086/337944
Roncari B, Pedroni M, Maffei S et al (2007) Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. Clin Genet 72:230–237. doi:10.1111/j.1399-0004.2007.00856.x
Kolodner RD, Tytell JD, Schmeits JL et al (1999) Germ-line MSH6 mutations in colorectal cancer families. Cancer Res 59:5068–5074
Vindigni SM, Kaz AM (2015) Universal screening of colorectal cancers for Lynch syndrome: challenges and opportunities. Dig Dis Sci. doi:10.1007/s10620-015-3964-6
Vasen HFA, Möslein G, Alonso A et al (2009) Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer 9:109–115. doi:10.1007/s10689-009-9291-3
Kidambi TD, Blanco A, Myers M et al (2015) Selective versus universal screening for Lynch syndrome: a six-year clinical experience. Dig Dis Sci 60:2463–2469. doi:10.1007/s10620-014-3234-z
Thiel A, Heinonen M, Kantonen J et al (2013) BRAF mutation in sporadic colorectal cancer and Lynch syndrome. Virchows Arch Int J Pathol 463:613–621. doi:10.1007/s00428-013-1470-9
Yamamoto H, Imai K (2015) Microsatellite instability: an update. Arch Toxicol 89:899–921. doi:10.1007/s00204-015-1474-0
Mange S, Bellcross C, Cragun D et al (2015) Creation of a network to promote universal screening for Lynch syndrome: the Lynch syndrome screening network. J Genet Couns 24:421–427. doi:10.1007/s10897-014-9770-z
Vasen HFA, Velthuizen ME, Kleibeuker JH et al (2016) Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry. Fam Cancer. doi:10.1007/s10689-016-9897-1
Hampel H (2016) Genetic counseling and cascade genetic testing in Lynch syndrome. Fam Cancer. doi:10.1007/s10689-016-9893-5
Acknowledgments
We are grateful to the members of the HNPCC families for their willingness to participate in this study and for, providing the blood samples. We thank Mr. Eric Clauser, Mr. Nadim Hamzaoui, Dr.Marie-Odile North, Mrs. Michèle Nigou and Mrs. Magalie Dambrun, members of Oncogenetic Laboratory, Cochin, Paris for their precious collaboration and excellent technical assistance and all members of the Biology and Genetics Laboratory, Medical Oncology service, University Hospital Center, Constantine, Algeria. We thank Dr. Zitouni Mina, Genomics and Biotechnology, Canada for reading and editing this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Ziada-Bouchaar, H., Sifi, K., Filali, T. et al. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome. Familial Cancer 16, 57–66 (2017). https://doi.org/10.1007/s10689-016-9917-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-016-9917-1